Skip to main content
. 2017 Aug 2;8(39):66169–66177. doi: 10.18632/oncotarget.19830

Table 2. Subgroup analyses in subset of included studies according to baseline characteristics for overall survival.

HR 95%CI Heterogeneity (%) P No. of included studies
Total 0.58 0.45 to 0.76 26.6 0.207 9
Study quality
 Quality score<7 0.62 0.44 to 0.89 27.5 0.228 6
 Quality score≤7 0.53 0.31 to 0.91 42.3 0.177 3
Research region
 USA 0.52 0.42 to 0.66 3.2 0.401 6
 Non-USA 1.21 0.57 to 2.54 0 0.606 3
Research center
 Single 0.76 0.52 to 1.11 14.3 0.323 6
 Multicenter 0.46 0.35 to 0.61 0 0.890 3
Sample size
 ≥400 0.58 0.40 to 0.82 24.8 0.256 5
 ≥400 0.61 0.38 to 1.00 46.2 0.134 4
First inclusion year
 Before 2000 0.60 0.45 to 0.82 21.9 0.269 6
 After 2000 0.52 0.27 to 1.03 53.3 0.118 3

CI= confidence intervence; DM: diabetes mellitus; HR= hazard ratios.